GEOVAX LABS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
GEOVAX LABS, INC. (GOVX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$61.53 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-05.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-05-05
- GEOVAX LABS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was -$61.53K.
- GEOVAX LABS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was -$286.02K.
- GEOVAX LABS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $352.95K, a 10.20% increase year-over-year.
- GEOVAX LABS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $40.43K.
- GEOVAX LABS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was $23.64K.
- GEOVAX LABS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$53.03K.
- GEOVAX LABS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$141.30K.
- GEOVAX LABS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$606.32K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 120 month | Cash and Cash Equivalents, Period Increase (Decrease) 123 month | Cash and Cash Equivalents, Period Increase (Decrease) 126 month | Cash and Cash Equivalents, Period Increase (Decrease) 129 month | Cash and Cash Equivalents, Period Increase (Decrease) 132 month | Cash and Cash Equivalents, Period Increase (Decrease) 135 month | Cash and Cash Equivalents, Period Increase (Decrease) 138 month | Cash and Cash Equivalents, Period Increase (Decrease) 141 month | Cash and Cash Equivalents, Period Increase (Decrease) 144 month | Cash and Cash Equivalents, Period Increase (Decrease) 147 month | Cash and Cash Equivalents, Period Increase (Decrease) 150 month | Cash and Cash Equivalents, Period Increase (Decrease) 153 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | -$61.53K 10-Q · filed 2020-05-05 | -$347.55K derived: sum of 2 quarters · filed 2020-05-05 | $5.40K derived: sum of 3 quarters · filed 2020-05-05 | $45.82K derived: sum of 4 quarters · filed 2020-05-05 | ||||||||||||
| 2019-12-31 | -$286.02K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | $66.93K derived: sum of 2 quarters · filed 2020-03-24 | $107.36K derived: sum of 3 quarters · filed 2020-03-24 | $23.64K 10-K · filed 2020-03-24 | ||||||||||||
| 2019-09-30 | $352.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $393.37K derived: sum of 2 quarters · filed 2019-11-07 | $309.66K 10-Q · filed 2019-11-07 | $58.12K derived: sum of 4 quarters · filed 2020-05-05 | ||||||||||||
| 2019-06-30 | $40.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$43.29K 10-Q · filed 2019-08-13 | -$294.83K derived: sum of 3 quarters · filed 2020-05-05 | $25.44K derived: sum of 4 quarters · filed 2020-05-05 | ||||||||||||
| 2019-03-31 | -$83.72K 10-Q · filed 2020-05-05 | -$335.26K derived: sum of 2 quarters · filed 2020-05-05 | -$14.98K derived: sum of 3 quarters · filed 2020-05-05 | -$395.17K derived: sum of 4 quarters · filed 2020-05-05 | ||||||||||||
| 2018-12-31 | -$251.54K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | $68.73K derived: sum of 2 quarters · filed 2020-03-24 | -$311.45K derived: sum of 3 quarters · filed 2020-03-24 | -$53.03K 10-K · filed 2020-03-24 | ||||||||||||
| 2018-09-30 | $320.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$59.91K derived: sum of 2 quarters · filed 2019-11-07 | $198.51K 10-Q · filed 2019-11-07 | $167.42K derived: sum of 4 quarters · filed 2019-11-07 | ||||||||||||
| 2018-06-30 | -$380.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$121.76K 10-Q · filed 2019-08-13 | -$152.86K derived: sum of 3 quarters · filed 2019-08-13 | -$631.63K derived: sum of 4 quarters · filed 2019-08-13 | ||||||||||||
| 2018-03-31 | $258.43K 10-Q · filed 2019-05-13 | $227.33K derived: sum of 2 quarters · filed 2019-05-13 | -$251.44K derived: sum of 3 quarters · filed 2019-05-13 | $404.40K derived: sum of 4 quarters · filed 2019-05-13 | ||||||||||||
| 2017-12-31 | -$31.10K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$509.87K derived: sum of 2 quarters · filed 2019-03-26 | $145.98K derived: sum of 3 quarters · filed 2019-03-26 | -$141.30K 10-K · filed 2019-03-26 | ||||||||||||
| 2017-09-30 | -$478.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $177.08K derived: sum of 2 quarters · filed 2018-11-08 | -$110.20K 10-Q · filed 2018-11-08 | -$167.27K derived: sum of 4 quarters · filed 2019-03-26 | ||||||||||||
| 2017-06-30 | $655.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $368.57K 10-Q · filed 2018-08-07 | $311.50K derived: sum of 3 quarters · filed 2019-03-26 | $607.47K derived: sum of 4 quarters · filed 2019-03-26 | ||||||||||||
| 2017-03-31 | -$287.28K 10-Q · filed 2018-05-03 | -$344.35K derived: sum of 2 quarters · filed 2019-03-26 | -$48.38K derived: sum of 3 quarters · filed 2019-03-26 | -$502.73K derived: sum of 4 quarters · filed 2019-03-26 | ||||||||||||
| 2016-12-31 | -$57.07K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $238.90K derived: sum of 2 quarters · filed 2019-03-26 | -$215.45K derived: sum of 3 quarters · filed 2019-03-26 | -$606.32K 10-K · filed 2019-03-26 | ||||||||||||
| 2016-09-30 | $295.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$158.39K derived: sum of 2 quarters · filed 2017-11-09 | -$549.25K 10-Q · filed 2017-11-09 | -$1.31M derived: sum of 4 quarters · filed 2018-03-23 | ||||||||||||
| 2016-06-30 | -$454.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$845.22K 10-Q · filed 2017-08-14 | -$1.61M derived: sum of 3 quarters · filed 2018-03-23 | -$2.26M derived: sum of 4 quarters · filed 2018-03-23 | ||||||||||||
| 2016-03-31 | -$390.87K 10-Q · filed 2017-05-12 | -$1.15M derived: sum of 2 quarters · filed 2018-03-23 | -$1.81M derived: sum of 3 quarters · filed 2018-03-23 | -$2.48M derived: sum of 4 quarters · filed 2018-03-23 | ||||||||||||
| 2015-12-31 | -$760.69K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | -$1.42M derived: sum of 2 quarters · filed 2018-03-23 | -$2.09M derived: sum of 3 quarters · filed 2018-03-23 | -$41.30K 10-K · filed 2018-03-23 | ||||||||||||
| 2015-09-30 | -$654.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$1.33M derived: sum of 2 quarters · filed 2016-11-14 | $719.39K 10-Q · filed 2016-11-14 | $958.85K derived: sum of 4 quarters · filed 2017-03-24 | ||||||||||||
| 2015-06-30 | -$671.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $1.37M 10-Q · filed 2016-08-05 | $1.61M derived: sum of 3 quarters · filed 2017-03-24 | $1.10M derived: sum of 4 quarters · filed 2017-03-24 | ||||||||||||
| 2015-03-31 | $2.05M 10-Q · filed 2016-05-04 | $2.28M derived: sum of 2 quarters · filed 2017-03-24 | $1.77M derived: sum of 3 quarters · filed 2017-03-24 | $1.14M derived: sum of 4 quarters · filed 2017-03-24 | ||||||||||||
| 2014-12-31 | $239.46K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | -$270.15K derived: sum of 2 quarters · filed 2017-03-24 | -$908.67K derived: sum of 3 quarters · filed 2017-03-24 | -$1.41M 10-K · filed 2017-03-24 | ||||||||||||
| 2014-09-30 | -$509.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$1.15M derived: sum of 2 quarters · filed 2015-11-12 | -$1.65M 10-Q · filed 2015-11-12 | -$858.42K derived: sum of 4 quarters · filed 2016-03-16 | ||||||||||||
| 2014-06-30 | -$638.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$1.14M 10-Q · filed 2015-08-04 | -$348.81K derived: sum of 3 quarters · filed 2016-03-16 | -$509.59K derived: sum of 4 quarters · filed 2016-03-16 | ||||||||||||
| 2014-03-31 | -$503.54K 10-Q · filed 2015-05-14 | $289.71K derived: sum of 2 quarters · filed 2016-03-16 | $128.93K derived: sum of 3 quarters · filed 2016-03-16 | $258.89K derived: sum of 4 quarters · filed 2016-03-16 | $2.01M 10-Q · filed 2014-05-02 | |||||||||||
| 2013-12-31 | $793.25K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $632.47K derived: sum of 2 quarters · filed 2016-03-16 | $762.42K derived: sum of 3 quarters · filed 2016-03-16 | $1.48M 10-K · filed 2016-03-16 | $2.51M 10-K · filed 2014-03-14 | |||||||||||
| 2013-09-30 | -$160.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$30.82K derived: sum of 2 quarters · filed 2014-11-12 | $684.69K 10-Q · filed 2014-11-12 | $136.80K derived: sum of 4 quarters · filed 2015-03-20 | $1.72M 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | $129.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $845.47K 10-Q · filed 2014-08-08 | $297.57K derived: sum of 3 quarters · filed 2015-03-20 | $64.38K derived: sum of 4 quarters · filed 2015-03-20 | $1.88M 10-Q · filed 2013-08-12 | |||||||||||
| 2013-03-31 | $715.51K 10-Q · filed 2014-05-02 | $167.62K derived: sum of 2 quarters · filed 2015-03-20 | -$65.58K derived: sum of 3 quarters · filed 2015-03-20 | -$489.05K derived: sum of 4 quarters · filed 2015-03-20 | $1.75M 10-Q · filed 2013-05-01 | |||||||||||
| 2012-12-31 | -$547.89K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-20 | -$781.09K derived: sum of 2 quarters · filed 2015-03-20 | -$1.20M derived: sum of 3 quarters · filed 2015-03-20 | -$132.06K 10-K · filed 2015-03-20 | $1.04M 10-K · filed 2013-03-18 | |||||||||||
| 2012-09-30 | -$233.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$656.67K derived: sum of 2 quarters · filed 2013-11-12 | $415.84K 10-Q · filed 2013-11-12 | $1.02M derived: sum of 4 quarters · filed 2014-03-14 | $1.58M 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | -$423.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $649.03K 10-Q · filed 2013-08-12 | $1.25M derived: sum of 3 quarters · filed 2014-03-14 | $1.15M derived: sum of 4 quarters · filed 2014-03-14 | $1.82M 10-Q · filed 2012-08-13 | |||||||||||
| 2012-03-31 | $1.07M 10-Q · filed 2013-05-01 | $1.67M derived: sum of 2 quarters · filed 2014-03-14 | $1.57M derived: sum of 3 quarters · filed 2014-03-14 | $1.70M derived: sum of 4 quarters · filed 2014-03-14 | $2.24M 10-Q · filed 2012-05-14 | |||||||||||
| 2011-12-31 | $601.32K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $499.93K derived: sum of 2 quarters · filed 2014-03-14 | $626.25K derived: sum of 3 quarters · filed 2014-03-14 | $88.89K 10-K · filed 2014-03-14 | $1.17M 10-K · filed 2012-03-30 | |||||||||||
| 2011-09-30 | -$101.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $24.93K derived: sum of 2 quarters · filed 2012-11-13 | -$512.43K 10-Q · filed 2012-11-13 | -$859.68K derived: sum of 4 quarters · filed 2013-03-18 | $566.66K 10-Q · filed 2011-11-10 | |||||||||||
| 2011-06-30 | $126.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | -$411.03K 10-Q · filed 2012-08-13 | -$758.29K derived: sum of 3 quarters · filed 2013-03-18 | -$1.14M derived: sum of 4 quarters · filed 2013-03-18 | $668.05K 10-Q · filed 2011-08-12 | |||||||||||
| 2011-03-31 | -$537.36K 10-Q · filed 2012-05-14 | -$884.62K derived: sum of 2 quarters · filed 2013-03-18 | -$1.27M derived: sum of 3 quarters · filed 2013-03-18 | |||||||||||||
| 2010-12-31 | -$347.25K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$728.56K derived: sum of 2 quarters · filed 2013-03-18 | -$2.44M 10-K · filed 2013-03-18 | |||||||||||||
| 2010-09-30 | -$381.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | -$2.09M 10-Q · filed 2011-11-10 | ||||||||||||||
| 2010-06-30 | -$1.71M 10-Q · filed 2011-08-12 | |||||||||||||||
| 2009-12-31 | $1.32M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |